Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.84 |
| ▸ | LMNA | P02545 | 1/20 | 0.84 |
| ▸ | PRKCA | P17252 | 4/20 | 0.77 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.77 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.77 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.77 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.67 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.67 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15167089 | 1.00 | ALDH1A1 (0.84) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9774345 | 1.00 | ALDH1A1 (0.84) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL15369302 | 1.00 | ALDH1A1 (0.84) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9774417 | 1.00 | ALDH1A1 (0.84) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9774325 | 1.00 | ALDH1A1 (0.84) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL3151121 | 0.95 | ALDH1A1 (0.87) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL3147074 | 0.95 | ALDH1A1 (0.87) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL10580269 | 0.94 | ALDH1A1 (0.74) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9576905 | 0.94 | ALDH1A1 (0.74) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL8534996 | 0.94 | ALDH1A1 (0.74) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2250241-B1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON USA INC (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-2250241-B1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON USA INC (US) | 2016-12-21 | — | — | EP | disclosed |
| US-9109238-B2 | Synthesis of diester-based lubricants from enzymatically-directed epoxides | CHEVRON U.S.A. INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150140623-A1 | Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides | NOVOZYMES A/S (DK) | 2015-05-21 | — | — | US | disclosed |
| US-20150140623-A1 | Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides | NOVOZYMES A/S (DK) | 2015-05-21 | — | — | US | disclosed |
| US-8575081-B2 | Synthesis of diester-based biolubricants from epoxides | CHEVRON U.S.A. INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575081-B2 | Synthesis of diester-based biolubricants from epoxides | CHEVRON U.S.A. INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8097740-B2 | Isolation and subsequent utilization of saturated fatty acids and α-olefins in the production of ester-based biolubricants | CHEVRON U.S.A. INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-8097740-B2 | Isolation and subsequent utilization of saturated fatty acids and α-olefins in the production of ester-based biolubricants | CHEVRON U.S.A. INC. (US) | 2012-01-17 | — | — | US | disclosed |
| US-20110077184-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON U.S.A. INC. (US) | 2011-03-31 | — | — | US | disclosed |
| US-20110077184-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON U.S.A. INC. (US) | 2011-03-31 | — | — | US | disclosed |
| US-7867959-B2 | Synthesis of diester-based biolubricants from epoxides | CHEVRON U.S.A. INC. (US) | 2011-01-11 | — | — | US | disclosed |
| EP-2250241-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | Chevron U.S.A. Inc. (US) | 2010-11-17 | — | — | EP | disclosed |
| WO-2010056832-A2 | SYNTHESIS OF DIESTER-BASED LUBRICANTS FROM ENZYMATICALLY-DIRECTED EPOXIDES | CHEVRON U.S.A. INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| US-20100120642-A1 | SYNTHESIS OF DIESTER-BASED LUBRICANTS FROM ENZYMATICALLY-DIRECTED EPOXIDES | CHEVRON U.S.A. INC. (US) | 2010-05-13 | — | — | US | disclosed |
| US-20090285728-A1 | ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS | CHEVRON U.S.A. INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090285728-A1 | ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS | CHEVRON U.S.A. INC. (US) | 2009-11-19 | — | — | US | disclosed |
| US-20090198075-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON U.S.A. INC. (US) | 2009-08-06 | — | — | US | disclosed |
| WO-2009097041-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON U.S.A. INC. (US) | 2009-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150140623-A1 | Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides | DGAT2, ADH1A, ELOVL1 | ALDH1A1 39/4885LMNA 4747/4885PRKCA 2013/4885 |
| US-20110077184-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | ELOVL1, ELOVL5, ELOVL3 | ALDH1A1 101/4885LMNA 4594/4885PRKCA 3899/4885 |
| US-20090198075-A1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | ELOVL5, ELOVL1, ELOVL3 | ALDH1A1 168/4885LMNA 4543/4885PRKCA 3780/4885 |
| US-20090285728-A1 | ISOLATION AND SUBSEQUENT UTILIZATION OF SATURATED FATTY ACIDS AND ALPHA-OLEFINS IN THE PRODUCTION OF ESTER-BASED BIOLUBRICANTS | ELOVL1, ELOVL5, FADS1 | ALDH1A1 490/4885LMNA 2358/4885PRKCA 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.